Driehaus Capital Management LLC Merus N.V. Transaction History

Driehaus Capital Management LLC

$10.2 Billion
Q3 2024

A detailed history of Driehaus Capital Management LLC transactions in Merus N.V. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 1,358,968 shares of MRUS stock, worth $56.9 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

1,358,968

Previous 1,550,009 12.33%

Holding current value

$56.9 Million

Previous $91.7 Million 25.97%

% of portfolio

0.67%

Previous 0.99%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$47.19 - $58.84 $9.02 Million - $11.2 Million	-191,041 Reduced 12.33%	1,358,968 $67.9 Million
Q2 2024 Aug 14, 2024	BUY	$39.81 - $60.2 $12.9 Million - $19.5 Million	323,518 Added 26.38%	1,550,009 $91.7 Million
Q1 2024 May 15, 2024	SELL	$28.03 - $51.82 $2.37 Million - $4.38 Million	-84,522 Reduced 6.45%	1,226,491 $55.2 Million
Q4 2023 Feb 14, 2024	BUY	$20.06 - $28.66 $3.53 Million - $5.04 Million	175,818 Added 15.49%	1,311,013 $36.1 Million
Q3 2023 Nov 14, 2023	SELL	$20.13 - $27.29 $30,617 - $41,508	-1,521 Reduced 0.13%	1,135,195 $26.8 Million
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $589,877 - $874,679	32,181 Added 2.91%	1,136,716 $29.9 Million
Q1 2023 May 15, 2023	BUY	$14.25 - $20.5 $442,434 - $636,484	31,048 Added 2.89%	1,104,535 $20.3 Million
Q4 2022 Feb 14, 2023	SELL	$12.8 - $23.66 $354,982 - $656,162	-27,733 Reduced 2.52%	1,073,487 $16.6 Million
Q3 2022 Nov 14, 2022	BUY	$18.64 - $28.93 $135,270 - $209,945	7,257 Added 0.66%	1,101,220 $22.1 Million
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $259,846 - $543,669	18,587 Added 1.73%	1,093,963 $24.8 Million
Q1 2022 May 16, 2022	SELL	$23.58 - $30.91 $502,324 - $658,475	-21,303 Reduced 1.94%	1,075,376 $28.4 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $8.55 Million - $13.8 Million	427,302 Added 63.84%	1,096,679 $34.9 Million
Q3 2021 Nov 15, 2021	SELL	$16.48 - $27.23 $5.52 Million - $9.12 Million	-335,101 Reduced 33.36%	669,377 $14.7 Million
Q2 2021 Aug 16, 2021	SELL	$20.0 - $25.48 $2.18 Million - $2.78 Million	-109,228 Reduced 9.81%	1,004,478 $21.2 Million
Q1 2021 May 17, 2021	BUY	$16.14 - $29.11 $5.96 Million - $10.8 Million	369,427 Added 49.64%	1,113,706 $23.3 Million
Q4 2020 Feb 16, 2021	BUY	$11.4 - $18.36 $2,861 - $4,608	251 Added 0.03%	744,279 $13 Million
Q3 2020 Nov 16, 2020	SELL	$10.57 - $16.0 $812,801 - $1.23 Million	-76,897 Reduced 9.37%	744,028 $8.93 Million
Q2 2020 Aug 14, 2020	SELL	$10.5 - $17.36 $5.53 Million - $9.15 Million	-527,092 Reduced 39.1%	820,925 $13.2 Million
Q1 2020 May 15, 2020	SELL	$11.34 - $19.44 $978,245 - $1.68 Million	-86,265 Reduced 6.01%	1,348,017 $16.3 Million
Q4 2019 Feb 12, 2020	BUY	$14.08 - $18.5 $11.4 Million - $15 Million	811,872 Added 130.44%	1,434,282 $20.2 Million
Q3 2019 Nov 14, 2019	BUY	$14.55 - $20.52 $9.06 Million - $12.8 Million	622,410 New	622,410 $11.1 Million

Others Institutions Holding MRUS

# of Institutions

200

Shares Held

61.9M

Call Options Held

243K

Put Options Held

300K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.92B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account

Driehaus Capital Management LLC Merus N.V. Transaction History